Waldenstrom's Disease
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia (NCT04893564) | Centre Hospitalier Universitaire, Amiens | 2022-05-16 |
| Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia (NCT03679624) | Weill Medical College of Cornell University | 2020-07-30 |
| Detection of Recurrent Mutations in Waldenström's Disease (NCT03952052) | Centre Henri Becquerel | 2019-01-14 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
Track Waldenstrom's Disease automatically
Every clearance here is in the API, with alerts when new ones post.